Multicultural group of people representing the importance of diversity in trials and recruitment.

A sponsor planning a Phase II trial needs to identify US investigators who could support its study, understand the patient landscape associated with each investigator, and support goals and objectives outlined in its FDA Race & Ethnicity Diversity Plan. See Sitetrove in action. 

Related resources

A diverse group of people looking up.
NOV 15, 2023
Article
Clinical

3 Ways Clinical Trial Diversity Can Put Sponsors On Top

Since the FDA’s draft guidance in 2022, the industry has redoubled its efforts to incorporate diversity at pivotal points in the clinical trial process.

A digital representation of the future of healthcare, showcasing the integration of technology and medicine.
JUN 01, 2023
White paper
Clinical

The Need for Better Diversity Data in Clinical Trial Benchmarking and Feasibility

Just as marginalized patients face barriers to clinical trial participation, study sponsors face challenges in obtaining clinical trial diversity data.

Accelerating Diversity Enrollment in a Phase III COVID-19 Clinical Trial
SEP 01, 2023
Use Case
Patient Engagement & Recruitment

Accelerating Diversity Enrollment in a Phase III COVID-19 Clinical Trial

A biotech need to rapidly meet diversity/inclusion goals for a high-profile Phase III COVID-19 trial. Citeline Connect helped the sponsor recover from a 72% decline in diversity-focused randomizations, delivering 20-25% of daily randomizations in 32 days.

Darkened Qualified calendar. Please allow all cookies to use functionality.

To enable the booking feature, please enable all cookies in your browser.